Literature DB >> 2776367

Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival.

F L Meyskens1, S P Thomson, J Buckmeier.   

Abstract

The efficiency of replating of cells from primary colonies grown in semisolid medium has been used to detect and quantitate self-renewal in vitro. A positive correlation has been found by others between the replating efficiency of cells from myelogenous leukemia and patient survival. In the current study we measured primary and secondary replating efficiency of metastatic melanoma cells from subcutaneous tissues or lymph nodes of twelve patients and related these results to patient survival from time of biopsy. No relationship was found between primary and secondary plating efficiency nor for primary or secondary replating efficiency and survival. These results suggest that colony-forming melanoma cells grown under anchorage-independent conditions do not identify a stem cell population important for survival distinct from highly proliferative cells. These studies do not, however, rule out the possibility that a non-clonogenic transitional cell population exists in the tumor.

Entities:  

Mesh:

Year:  1989        PMID: 2776367     DOI: 10.1007/BF01753673

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

1.  Stem cells in differentiation and neoplasia.

Authors:  J E Till
Journal:  J Cell Physiol Suppl       Date:  1982

2.  Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia.

Authors:  R N Buick; M D Minden; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

3.  Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma.

Authors:  F L Meyskens; L Loescher; T E Moon; B Takasugi; S E Salmon
Journal:  J Clin Oncol       Date:  1984-11       Impact factor: 44.544

4.  A stem cell model of human tumor growth: implications for tumor cell clonogenic assays.

Authors:  W J Mackillop; A Ciampi; J E Till; R N Buick
Journal:  J Natl Cancer Inst       Date:  1983-01       Impact factor: 13.506

5.  Cellular heterogeneity in normal and neoplastic human urothelium.

Authors:  W J Mackillop; J P Bizarri; G K Ward
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

6.  Method for measurement of self-renewal capacity of clonogenic cells from biopsies of metastatic human malignant melanoma.

Authors:  S P Thomson; F L Meyskens
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

7.  Multi-type Galton-Watson process as a model for proliferating human tumour cell populations derived from stem cells: estimation of stem cell self-renewal probabilities in human ovarian carcinomas.

Authors:  A Ciampi; L Kates; R Buick; Y Kriukov; J E Till
Journal:  Cell Tissue Kinet       Date:  1986-03

8.  New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.

Authors:  S E Salmon; F L Meyskens; D S Alberts; B Soehnlen; L Young
Journal:  Cancer Treat Rep       Date:  1981 Jan-Feb

9.  Density/volume analysis in the study of cellular heterogeneity in human ovarian carcinoma.

Authors:  W J Mackillop; S S Stewart; R N Buick
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

10.  Measurement of self-renewal in culture of clonogenic cells from human ovarian carcinoma.

Authors:  R N Buick; W J MacKillop
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.